Transgene Biotek Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2025 ,inter alia, to consider and approve 1) To Consider and approve the Audited Financial Results (Standalone and consolidated) of the Company for the fourth quarter and financial year ended March 31, 2025.\r\n\r\n2) Any Other Business matter, with the permission of the Chair.